Corporate Compliance

At Endo Pharmaceuticals we take our responsibility to patients, healthcare providers and shareholders very seriously and we are committed to fostering a company culture that supports conducting business in a compliant and ethical manner. The Compliance and Business Practices Department oversees Endo Pharmaceutical’s compliance program which is founded on the Company’s values of respect, trust and integrity and serves as a basis for a proactive and sustainable approach to ethics and compliance. For more information on Endo’s comprehensive compliance program link to Endo's Corporate Compliance & Business Practices page.

On February 21, 2014, Endo Pharmaceuticals reached a resolution of criminal and civil claims with federal and participating state authorities regarding a previously disclosed investigation concerning past US sales, marketing and promotional practices.  As a part of the settlement, Endo Pharmaceuticals has entered into a Deferred Prosecution Agreement (DPA) with the United States Department of Justice for a period of up to 2 ½ years and a Corporate Integrity Agreement (CIA) with the United States Department of Health and Human Services, Office of Inspector General for a period of  5 years.  The agreements build on Endo's existing comprehensive compliance program.  Endo is committed to conducting our business in a compliant and ethical manner.  

For more information access the following:

*By clicking on the link(s) on this page you will leave the website and move to an external website(s) independently operated and not managed by Endo Pharmaceuticals. Because Endo Pharmaceuticals does not control the content of the website(s) you are about to visit, and due to its constantly changing nature, we cannot be responsible for its content, accuracy, practices, or standards.

About Endo


Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.


You are now leaving the website

Cancel Continue